Although the absolute risk for severe COVID-19 in pregnancy remains low, it is now established that pregnant women are at increased risk of severe COVID-19-associated illness compared with non-pregnant women. Such illness may require hospitalisation, admission to intensive care, mechanical ventilation and even cause death. Thus, the prevention of critical COVID-19 infection is of paramount importance for both the mother and her fetus.
Based on the available evidence, FIGO considers there to be minimal risks – actual or theoretical – that would outweigh the potential benefits of vaccination for pregnant women. We therefore support offering COVID-19 vaccines to pregnant and breastfeeding women.
In this webinar, leading speakers will set out FIGO’s position on COVID-19 vaccination and also explore the need for counselling skills for OBGYNs to ensure women can make informed choices. Taking a risk-based approach to the benefits of universal protection, our expert speakers will discuss the safety, efficacy and indications of the various vaccines for pregnant and breastfeeding women.
Dr Faysal El Kak - Vice-President, FIGO (Lebanon)
Dr Jeanne Conry - President-Elect, FIGO (USA)
Professor Dame Lesley Regan - Honorary Secretary, FIGO (UK)
Dr Carlos Füchtner - President, FIGO (Bolivia)
Dr Denise Jamieson (USA)
Dr Frank A. Chervenak (USA)
Dr Anwar Nassar (Lebanon)